| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| [Ala26, Leu27]-Melan-A (26-35);ALAGIGILTV |
|
|
詳細(xì)
|
| [Ala26]-Melan-A/MART-1 (26-35);AAAGIGILTV |
|
|
詳細(xì)
|
| [Ala6,D-Trp8]-Galanin (1-15)-ol;GWTLNAAwYLLGPHA-ol |
|
|
詳細(xì)
|
| [Cys3,6, Tyr8, Pro9]-Substance P;RPCPQCFYPLM-NH2(Disulfidebridge:3-6) |
|
141459-28-1 |
詳細(xì)
|
| [D-Arg25]-Neuropeptide Y, human, rat;YPSKPDNPGEDAPAEDMARYYSALrHYINLITRQRY-NH2 |
|
|
詳細(xì)
|
| [Deamino-Cys1, D-Arg8]-Vasopressin, free acid;3-Mercaptopropionyl-YFQNCPrG(Disulfidebridge:1-6) |
|
|
詳細(xì)
|
| [Des-Ac]-α-MSH, amide;SYSMEHFRWGKPV-NH2 |
|
|
詳細(xì)
|
| [Des-Arg10]-HOE I40;rRP-Hyp-G-Thi-S-(D-Tic)-Oic |
|
|
詳細(xì)
|
| [D-His26]-Neuropeptide Y, human, rat;YPSKPDNPGEDAPAEDMARYYSALRhYINLITRQRY-NH2 |
|
|
詳細(xì)
|
| [D-Trp34]-Neuropeptide Y, human;YPSKPDNPGEDAPAEDMARYYSALRHYINLITRwRY-NH2 |
|
|
詳細(xì)
|
| [D-Trp6,8,9]-Galanin (1-15)-ol;GWTLNwAwwLLGPHA-ol |
|
|
詳細(xì)
|
| [D-Tyr11]-Neurotensin;Pyr-LYENKPRRPyIL |
|
39379-15-2 |
詳細(xì)
|
| [D-Tyr6, ?-Ala11, ?-Phe13, Nle14]-Bombesin (1-14);Pyr-QRLGyQWAV-(?-A)-H-(?-F)-Nle-NH2 |
|
|
詳細(xì)
|
| [D-Tyr6, ?-Ala11, Phe13, Nle14]-Bombesin (6-14);yQWAV-(?-A)-HF-Nle-NH2 |
|
|
詳細(xì)
|
| [Gln11]-beta-Amyloid (1-40);DAEFRHDSGYQVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
|
106686-61-7 |
詳細(xì)
|
| [Gln144]-PLP (139-151), Q144-PLP(139-151);HSLGKQLGHPDKF |
|
|
詳細(xì)
|
| [Gln22]-beta-Amyloid (1-40);DAEFRHDSGYEVHHQKLVFFAQDVGSNKGAIIGLMVGGVV |
|
|
詳細(xì)
|
| [Gln22]-beta-Amyloid (6-40);HDSGYEVHHQKLVFFAQDVGSNKGAIIGLMVGGVV |
|
|
詳細(xì)
|
| [Gly22]-beta-Amyloid (1-40);DAEFRHDSGYEVHHQKLVFFAGDVGSNKGAIIGLMVGGVV |
|
|
詳細(xì)
|
| [Gly30, Cys31] β-Amyloid (13-31)??NEW;HHQKLVFFAEDVGSNKGGC |
|
|
詳細(xì)
|
| [Ile34] Beta-Amyloid (25-34);GSNKGAIIGI |
|
|
詳細(xì)
|
| [Leu144]-PLP (139-151), L144-PLP(139-151);HSLGKLLGHPDKF |
|
|
詳細(xì)
|
| [Leu27]-Melan-A, MART 1 (26-35);ELAGIGILTV |
|
|
詳細(xì)
|
| [Leu28]-Melan-A (27-35);ALGIGILTV |
|
|
詳細(xì)
|
| [Lys0]-γ-1-MSH (41-58), amide;KYVMGHFRWDRFG-NH2 |
|
|
詳細(xì)
|
| [Lys4]-Sarafotoxin 6c;CTCKDMTDEECLNFCHQDVIW(Disulfidebridge:1-15and3-11) |
|
|
詳細(xì)
|
| [Lys5, NMeLeu9, NIe10]-Neurokinin A (4-10);DKFVG-(NMeL)-NIe-NH2 |
|
|
詳細(xì)
|
| [Nle35] beta-Amyloid (17-42);LVFFAEDVGSNKGAIIGL-Nle-VGGVVIA |
|
|
詳細(xì)
|
| [Nle35]-beta-Amyloid (1-40);DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGL-Nle-VGGVV |
|
|
詳細(xì)
|
| [Nle35]-beta-Amyloid (1-42);DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGL-Nle-VGGVVIA |
|
|
詳細(xì)
|
| [Nle35]-Beta-Amyloid (25-35);GSNKGAIIGL-Nle |
|
|
詳細(xì)
|
| [pS119] CREB327 (113-126), Biotinyl??;Biotin-ILSRRP(pS)YRKILND |
|
|
詳細(xì)
|
| [pSer5]-Kemptide, 5-TMR labeled;5-TMR-LRRA-pS-LG |
|
|
詳細(xì)
|
| [pSer5]-Kemptide, Biotinylated, Amide;Biotin-LRRA-pS-LG-NH2 |
|
|
詳細(xì)
|
| 520 MMP FRET Substrate X;QXL?520-Pro-Leu-Ala-Tyr-Trp-Ala-Arg-Lys(5-FAM)-NH2 |
|
|
詳細(xì)
|
| 520 MMP FRET Substrate VIII;QXL?520-RPKPLA-Nva-WK(5-FAM)-NH2 |
|
|
詳細(xì)
|
| 520 MMP FRET Substrate VII;QXL?520-PYAYWMRK(5-FAM)-NH2 |
|
|
詳細(xì)
|
| 520 MMP FRET Substrate VI;QXL?520-Pro-Leu-Gly-Met-Trp-Ser-Arg-Lys(5-FAM)-NH2 |
|
|
詳細(xì)
|
| 520 MMP FRET Substrate V;5-FAM-Pro-Leu-Gly-Leu-Dap(QXL?520)-Ala-Arg-NH2 |
|
|
詳細(xì)
|
| 520 MMP FRET Substrate IX;QXL?520-RPLALWRK(5-FAM)-NH2 |
|
|
詳細(xì)
|
| 520 MMP FRET Substrate IV;5-FAM-Pro-Leu-Ala-Nva-Dap(QXL?520)-Ala-Arg-NH2 |
|
|
詳細(xì)
|
| 520 MMP FRET Substrate III;QXL?520-Pro-Leu-Gly-Cys(Me)-His-Ala-Arg-Lys(5-FAM)-NH2 |
|
|
詳細(xì)
|
| 520 MMP FRET Substrate II;QXL?520-Pro-Leu-Ala-Leu-Trp-Ala-Arg-Lys(5-FAM)-NH2 |
|
|
詳細(xì)
|
| [pSer5]-Kemptide, Biotinylated-LC;Biotin-LC-LRRA-pS-LG |
|
|
詳細(xì)
|
| [pSer5]-Kemptide, HiLyte Fluor? 488 labeled;HiLyteFluor?488-LRRA-pS-LG |
|
|
詳細(xì)
|
| [Pyr11]-beta-Amyloid (11-40);Pyr-VHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
|
|
詳細(xì)
|
| [Pyr11]-beta-Amyloid (11-42);Pyr-VHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
|
|
詳細(xì)
|
| [Pyr3]-beta-Amyloid (3-40);Pyr-FRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
|
|
詳細(xì)
|
| [Pyr3]-beta-Amyloid (3-42);Pyr-FRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
|
183449-57-2 |
詳細(xì)
|
| [Ser102]-MCC (88-103), MCC (T102S);ANERADLIAYLKQASK |
|
|
詳細(xì)
|
| [Tyr0]-Corticotropin Releasing Factor, [Tyr0]-CRF, human, rat;YSEEPPISLDLTFHLLREVLEEMARAEQLAQQAHSNRKLMEII-NH2 |
|
100513-58-4 |
詳細(xì)
|
| [Tyr0]-Corticotropin Releasing Factor, [Tyr0]-CRF, ovine;YSQEPPISLDLTFHLLREVLEMTKADQLAQQAHSNRKLLDIA-NH2 |
|
|
詳細(xì)
|
| [Tyr0]-α-Calcitonin Gene Related Peptide, [Tyr0]-α-CGRP, rat;YSCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH2(Disulfidebridge:2-7) |
|
|
詳細(xì)
|
| [Tyr11] Head Activator;Pyr-PPGGSKVILY |
|
|
詳細(xì)
|
| [Tyr22]-α-CGRP (22-37), rat;YVKDNFVPTNVGSEAF-NH2 |
|
|
詳細(xì)
|
| [Tyr8]-Atrial Natriuretic Peptide (5-27), [Tyr8]-Atriopeptin II, rat;SSCYGGRIDRIGAQSGLGCNSFR(Disulfidebridge:3-19) |
|
|
詳細(xì)
|
| Beta-Amyloid (1-40);DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
|
|
詳細(xì)
|
| 2837b, Hemoglobin Fragment, Plasmepsin II (PM II) substrate, EDANS/ DABCYL??;EDANS-CO-CH2-CH2-CO-Ala-Leu-Glu-Arg-Met-Phe-Leu-Ser-Phe-Pro-Dap(DABCYL)-OH |
|
|
詳細(xì)
|
| 390 MMP FRET Substrate II;Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-OH |
|
|
詳細(xì)
|
| 490 MMP FRET Substrate III;DABCYL-RPLALWRS-EDANS |
|
|
詳細(xì)
|
| 490 MMP FRET Substrate IV;DabcylPlus-Lys-Pro-Leu-Ala-Nva-Asp(EDANS)-Ala-Arg-NH2 |
|
|
詳細(xì)
|
| 490 MMP FRET Substrate V;NBD-RPKPLA-Nva-WK(DMC)-NH2 |
|
|
詳細(xì)
|
| 490 MMP FRET Substrate VI;DabcylPlus-Lys-Pro-Leu-Ala-Nva-Dap(AMCA)-Ala-Arg-NH2 |
|
|
詳細(xì)
|
| 490 MMP FRET Substrate VII;Dabcyl-Lys-Pro-Leu-Ala-Nva-Dap(AMCA-X)-NH2 |
|
|
詳細(xì)
|
| 4A/4B Peptide (2);DEMEECASHLPY-K(Ac)-NH2 |
|
|
詳細(xì)
|
| 4A/4B Peptide (3), EDANS-labeled;DEMEECASHLPY-E(EDANS)-NH2 |
|
|
詳細(xì)
|
| 520 MMP FRET Substrate I;QXL520?-Pro-Leu-Gly-Leu-Trp-Ala-D-Arg-Lys(5-FAM)-NH2 |
|
|
詳細(xì)
|
| 5A, pNA-labeled;EDVV-Abu-C-pNA |
|
|
詳細(xì)
|
| 580 MMP FRET Substrate I;QXL?570-Lys-Pro-Leu-Ala-Nva-Dap(5-TAMRA)-Ala-Arg-NH2 |
|
|
詳細(xì)
|
| 520 MMP FRET Substrate XVII;QXL?520-Lys-Pro-Leu-Ala-Nva-Dap(5-FAM)-Ala-Arg-NH2 |
|
|
詳細(xì)
|
| 520 MMP FRET Substrate XVI;QXL?520-RPKPQQFWK(5-FAM)-NH2 |
|
|
詳細(xì)
|
| 520 MMP FRET Substrate XV;QXL?520-γ-Abu-Pro-Gln-Gly-Leu-Dab(5-FAM)-Ala-Lys-NH2 |
|
|
詳細(xì)
|
| 520 MMP FRET Substrate XIV;QXL?520-γ-Abu-Pro-Cha-Abu-Smc-His-Ala-Dab(5-FAM)-Ala-Lys-NH2(Smc=S-Methyl-L-cysteine) |
|
|
詳細(xì)
|
| 520 MMP FRET Substrate XIII;5-FAM-RPKPVE-Nva-WRK(QXL?520)-NH2 |
|
|
詳細(xì)
|
| 520 MMP FRET Substrate XII;5-FAM-RPKPYA-Nva-WM-K(QXL?520)-NH2 |
|
|
詳細(xì)
|
| 520 MMP FRET Substrate XI;5-FAM-Pro-Cha-Gly-Nva-His-Ala-Dap(QXL?520)-NH2 |
|
|
詳細(xì)
|
| β-Secretase Substrate I, Fluorogenic |
|
|
詳細(xì)
|
| δ1-MSH, amide |
|
72629-65-3 |
詳細(xì)
|
| γ-2-MSH (41-58), amide;YVMGHFRWDRFG-NH2 |
|
|
詳細(xì)
|
| γ3-MSH:GAMMA3-MSH |
|
72629-64-2 |
詳細(xì)
|
| γ-Endorphin |
|
60893-02-9 |
詳細(xì)
|
| γ-MSH (3-8) |
|
|
詳細(xì)
|
| γ-TAC4 (30-61)-NH2??;TEAETWEGAGPSIQLQLQEVKTGKASQFFGLM-NH2 |
|
|
詳細(xì)
|
| δ-Endorphin (bovine, camel, mouse, ovine) |
|
66954-40-3 |
詳細(xì)
|
| δ-Endorphin (human) |
|
76622-84-9 |
詳細(xì)
|
| BREMELANOTIDE |
布雷默浪丹;PT 141;PT-141 |
189691-06-3 |
詳細(xì)
|
| Cetrorelix Acid; |
|
120287-85-6 |
詳細(xì)
|
|
|
|
詳細(xì)
|
| (Arg)9, FAM-labeled;FAM-RRRRRRRRR |
|
|
詳細(xì)
|
| (Arg)9, TAMRA-labeled;TAMRA-RRRRRRRRR |
|
|
詳細(xì)
|
| (pS8, pS13) Eucariotic Translation Initiation Factor 2B, eIF2B??;RRAAEELDpSRAGpSPQL |
|
|
詳細(xì)
|
| (Z-AR)2Rh110?2HCl;(Z-AR)2Rh110?HCl |
|
|
詳細(xì)
|
| (Z-Arg)2Rh110 ? 2HCl;(Z-R)2Rh110?2HCl |
|
|
詳細(xì)
|
| (Z-Phe-Arg)2Rh110;(Z-FR)2Rh110 |
|
|
詳細(xì)
|
| ?-Bag Cell Peptide;RLRFH |
|
|
詳細(xì)
|
| ?-Neuroprotectin;aDLIAYL-NH2 |
|
|
詳細(xì)
|
| [3,4-Dehydro-Pro]3-Thyrotropin Releasing Hormone, [ΔPro3]-TRH |
|
|
詳細(xì)
|
| [4-Chloro-Phe]7,8-Substance P;RPKPQQ-F(4-Cl-F)-GLM-NH2 |
|
73646-81-8 |
詳細(xì)
|
| [Ala144]-PLP (139-151) A144-PLP(139-151);HSLGKALGHPDKF |
|
|
詳細(xì)
|
| β-Endorphin, equine |
|
|
詳細(xì)
|